Antibody Drug Conjugates Market Size, Trends, and Growth Analysis (2023–2031)
The global antibody drug conjugates (ADC) market is witnessing remarkable expansion, driven by advancements in targeted cancer therapies and increasing investment in oncology research. ADCs combine monoclonal antibodies with cytotoxic drugs, enabling precise delivery of chemotherapy directly to cancer cells while minimizing damage to healthy tissues. This targeted approach has positioned ADCs...